18+ hour, 36+ min ago  (551+ words) Merck KGa A has inked a collaboration deal with Israeli-US startup, Remepy, to explore the therapeutic potential of combination drug and app-based approaches in rare oncology " marking the first big pharma foray into this new evolving area for digital therapies....

19+ hour, 14+ min ago  (554+ words) Seaport will use the funds for its neuropsychiatric drug pipeline, while Hemab will focus on bleeding disorder medicines. Seaport Therapeutics and Hemab Therapeutics have both outlined pricings for their respective initial public offerings (IPOs), adding to an already busy month…...

1+ day, 14+ hour ago  (489+ words) Ajax's lead asset is AJ1-11095, a once-daily Type II JAK2 inhibitor taken orally, which is currently in a Phase I trial. Eli Lilly has added yet another string to its M&A bow of 2026 after agreeing to acquire cancer specialist Ajax Therapeutics…...

1+ day, 10+ hour ago  (491+ words) Pharmaceutical Technology Bowel cancer, also known as colorectal cancer, is the second most lethal cancer after lung cancer, with the highest incidence rates being reported in developed countries. According to Cancer Research UK, bowel cancer is the fourth most common…...

1+ day, 14+ hour ago  (257+ words) Pharmaceutical Technology At the Pharma Meets AI conference in Barcelona, Spain, in April 2026, discussions around AI governance highlighted a clear shift from high-level policy frameworks to more integrated, operational models. As artificial intelligence (AI) adoption scales across pharmaceutical organisations, governance…...

1+ day, 18+ hour ago  (628+ words) With an uptick and increasingly even spread of capital across the space, the BIA's Martin Turner is optimistic for British biotech's future. New data debuted by the UK's Bio Industry Association (BIA) has hinted towards the recovery of the British…...

1+ day, 19+ hour ago  (635+ words) Novartis" Rhapsido has won approval in Europe, while Coartem Baby has received WHO prequalification. Novartis has netted a pair of regulatory wins, winning European approval for an oral therapy in chronic spontaneous urticaria (CSU) and, separately, receiving World Health Organization…...

4+ day, 10+ hour ago  (718+ words) Ann Mongan, director of translational research at BMS, outlines how biomarkers hold pivotal roles in clinical trials. Clinicians have often pushed for certain biomarkers to move from serving a purely informative role in clinical trials to becoming surrogate endpoints, which…...

4+ day, 14+ hour ago  (369+ words) Pharmaceutical Technology On 20 April 2026, Biogen announced that it would acquire exclusive rights to TJ Biopharma's anti-CD38 immunotherapy, felzartamab, in the Greater China region for up to $850m, granting it global rights to the drug. Biogen will also gain control of the…...

4+ day, 13+ hour ago  (566+ words) Pharmaceutical Technology Historically, migraine prevention has been managed with a wide variety of non-migraine-specific drug classes, such as beta-adrenergic receptor blockers, calcium antagonists, antidepressants, and anti-epileptics including topiramate. However, many of these oral preventive treatments have been associated with poor…...